Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens

Haematologica

Volumn 85, Issue 12, 2000, Pages 1255-1260

  Rossini, F ^a   Verga, M ^a   Pioltelli, P ^a   Giltri, G ^a   Sancassani, V ^a   Pogliani, E M ^a   Corneo, G ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Acute leukemia; Anthracyclines; Antibiotic therapy; Immunocompromised host; Pneumonia

Indexed keywords

AMIKACIN; AMPHOTERICIN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; ITRACONAZOLE; NYSTATIN; PREDNISONE; RETINOIC ACID; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; DEATH; FEMALE; HUMAN; INCIDENCE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PNEUMONIA; PROGNOSIS; RISK FACTOR;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; PNEUMONIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034508472     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: Outcome and prognostic factors
2. Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study
3. Unusual invasive bronchial aspergillosis in a patient with acute lymphoblastic leukemia
4. Outcome of respiratory failure in haematologic malignancy
5. Etiology and management of the compromised patient with fever and pulmonary infiltrates
6. Chlamydia pneumoniae pneumonia with acute hemorrhagic pericarditis in a patient with acute leukemia
7. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: Results of the phase II Gemia protocol
8. Clinical presentation of infection of granulocytopenic patients
9. Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndrome
10. Pneumonia in acute leukemia
11. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive mangement
12. The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies
13. Trends in post-mortem epidemiology of invasive fungal infections at a University Hospital
14. Diagnosis and prevention of fungal infection in the immunocompromized patients
15. Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukaemia
16. Fungal infections and fever of unknown origin in neutropenic patients
17. Pneumonia during remission induction chemotherapy in patients with AML or MDS
18. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized placebo-controlled, double-blind, multicentric trial
19. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
20. Liposomal amphotericin B for empirical therapy in patients with persistant fever and neutropenia
21. A randomised double-blind comparative safety trial of AmBisome and Abelcet in febrile neutropenic patients